«Juvenile» oncology - A missing subspecialty. The experience of a reference cancer centre
dc.contributor.author | Pentheroudakis, George | en |
dc.contributor.author | Mauri, D. | en |
dc.contributor.author | Kostadima, Lida | en |
dc.contributor.author | Golfinopoulos, Vassilis | en |
dc.contributor.author | Alexiou, G. | en |
dc.contributor.author | Karakatsanis, A. | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.creator | Pentheroudakis, George | en |
dc.creator | Mauri, D. | en |
dc.creator | Kostadima, Lida | en |
dc.creator | Golfinopoulos, Vassilis | en |
dc.creator | Alexiou, G. | en |
dc.creator | Karakatsanis, A. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.date.accessioned | 2018-06-22T09:54:25Z | |
dc.date.available | 2018-06-22T09:54:25Z | |
dc.date.issued | 2006 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42347 | |
dc.description.abstract | Introduction: Despite unique tumor epidemiology and a higher cancer incidence compared to pediatric patients, adolescents and young adults have not been receiving specialized, multidisciplinary, centralized care. In an effort to emphasize this need, we present outcome and toxicity data from a reference centre. Methods: Cohort of 150 patients aged 15-30 treated for malignant tumors of lymphoid and solid organs from 1986 to 2002. Results: Patients aged 15-19 commonly had lymphomas, germ cell tumors and pediatric sarcomas, whereas those aged 20-30 experienced germ cell tumors, lymphomas, melanomas and epithelial tumors more often. Overall 5- and 10-year survival was 80%, whereas 5-year and 10-year time to treatment failure was 68% and 43.5% respectively. 24% of patients experienced persistent, late treatment-related toxicities that interfered with their normal lifestyle. Conclusion: Despite the need for specialized care, psychosocial support and enrollment in clinical trials, youngsters have not been recognized as a patient group with distinct needs. Development of «Juvenile» oncology is required. © FESEO 2006. | en |
dc.language.iso | eng | en |
dc.source | Clinical and Translational Oncology | en |
dc.subject | Greece | en |
dc.subject | Article | en |
dc.subject | Antineoplastic agent | en |
dc.subject | Antineoplastic agents | en |
dc.subject | Bleomycin | en |
dc.subject | Chlormethine | en |
dc.subject | Cisplatin | en |
dc.subject | Dacarbazine | en |
dc.subject | Doxorubicin | en |
dc.subject | Human | en |
dc.subject | Neoplasms | en |
dc.subject | Patient care | en |
dc.subject | Prednisone | en |
dc.subject | Procarbazine | en |
dc.subject | Vinblastine | en |
dc.subject | Vincristine | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Controlled study | en |
dc.subject | Female | en |
dc.subject | Major clinical study | en |
dc.subject | Oncology | en |
dc.subject | Cancer survival | en |
dc.subject | Chemotherapy | en |
dc.subject | Ovary cancer | en |
dc.subject | Retrospective studies | en |
dc.subject | Retrospective study | en |
dc.subject | Taxane derivative | en |
dc.subject | Survival analysis | en |
dc.subject | Disease free survival | en |
dc.subject | Survival | en |
dc.subject | Survival rate | en |
dc.subject | Hospitals | en |
dc.subject | Cancer research | en |
dc.subject | Adolescent | en |
dc.subject | Overall survival | en |
dc.subject | Cancer radiotherapy | en |
dc.subject | Hodgkin disease | en |
dc.subject | Nonhodgkin lymphoma | en |
dc.subject | Colorectal cancer | en |
dc.subject | Melanoma | en |
dc.subject | Neoplasm | en |
dc.subject | Sarcoma | en |
dc.subject | Male | en |
dc.subject | Incidence | en |
dc.subject | Neurologic disease | en |
dc.subject | Side effect | en |
dc.subject | Cancer center | en |
dc.subject | Stomach cancer | en |
dc.subject | Cancer incidence | en |
dc.subject | Liver cell carcinoma | en |
dc.subject | Cancer | en |
dc.subject | Multiple cycle treatment | en |
dc.subject | Liver dysfunction | en |
dc.subject | Nitrosourea | en |
dc.subject | Proctitis | en |
dc.subject | Xerostomia | en |
dc.subject | Quality of life | en |
dc.subject | Vinca alkaloid | en |
dc.subject | Depression | en |
dc.subject | Heart disease | en |
dc.subject | Kidney cancer | en |
dc.subject | Social support | en |
dc.subject | Psychological aspect | en |
dc.subject | Germ cell tumor | en |
dc.subject | Medical specialist | en |
dc.subject | Patient referral | en |
dc.subject | Lymphoma | en |
dc.subject | Interdisciplinary communication | en |
dc.subject | University | en |
dc.subject | Statistics | en |
dc.subject | Ear disease | en |
dc.subject | Heart left ventricle ejection fraction | en |
dc.subject | Treatment failure | en |
dc.subject | Adolescents | en |
dc.subject | Cancer epidemiology | en |
dc.subject | Lifestyle | en |
dc.subject | University hospital | en |
dc.subject | Medical oncology | en |
dc.subject | Infertility | en |
dc.subject | Childhood cancer | en |
dc.subject | Testis cancer | en |
dc.subject | Raynaud phenomenon | en |
dc.subject | Soft tissue sarcoma | en |
dc.subject | Academic medical centers | en |
dc.subject | Amenorrhea | en |
dc.subject | Anus cancer | en |
dc.subject | Azoospermia | en |
dc.subject | Bladder obstruction | en |
dc.subject | Cancer care facilities | en |
dc.subject | Diagnosis related group | en |
dc.subject | Diagnosis-related groups | en |
dc.subject | Endocrine disease | en |
dc.subject | Epithelium tumor | en |
dc.subject | Femur head necrosis | en |
dc.subject | Health care delivery | en |
dc.subject | Health care need | en |
dc.subject | Juvenile oncology | en |
dc.subject | Lymphedema | en |
dc.subject | Osteosarcoma | en |
dc.subject | Patient care team | en |
dc.subject | Pediatrics | en |
dc.subject | Postoperative complication | en |
dc.subject | Postoperative complications | en |
dc.subject | Psychosocial care | en |
dc.subject | Radiotherapy | en |
dc.subject | Referral and consultation | en |
dc.subject | Small intestine cancer | en |
dc.subject | Sudden death | en |
dc.subject | Young adults | en |
dc.title | «Juvenile» oncology - A missing subspecialty. The experience of a reference cancer centre | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1007/s12094-006-0199-1 | |
dc.description.volume | 8 | |
dc.description.issue | 6 | |
dc.description.startingpage | 444 | |
dc.description.endingpage | 449 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Pentheroudakis, George [0000-0002-6632-2462] | |
dc.contributor.orcid | Karakatsanis, A. [0000-0002-5509-8645] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-6632-2462 | |
dc.gnosis.orcid | 0000-0002-5509-8645 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |